Characterization of the immunostimulants levamisole and tetramisole
- 31 August 1975
- journal article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 11 (8), 555-563
- https://doi.org/10.1016/0014-2964(75)90127-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: Studies on cell-mediated immunity and humoral antibody responseEuropean Journal of Cancer (1965), 1975
- Selective antimetastatic treatment—current status and future prospectsCancer Treatment Reviews, 1974
- Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG‐treated mice in vitroInternational Journal of Cancer, 1974
- Levamisole inactive in treatment of four animal tumoursNature, 1974
- Restoration of host defense mechanisms in man by levamisoleLife Sciences, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Role of T lymphocytes in the pathogenesis of experimental autoimmune encephalomyelitisEuropean Journal of Immunology, 1973
- Inhibitory effects of BCG on adenovirus tumorigenesis: Dependence on administration scheduleInternational Journal of Cancer, 1972
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- Plaque Formation in Agar by Single Antibody-Producing CellsScience, 1963